Aggregated China Business Blogs



Shengtai Pharmaceutical: A Steal at Current Prices

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
March 31, 2008|

Shengtai Pharmaceutical (SGTI.OB) offers growth of over 40% p.a. (past and future), with a p/e of 4.5, a leading market share of 30%, and an uplisting from the OTCBB to Nasdaq as soon as the stock price stays above $4 for 30 days (paperwork has already been prepared).

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Shengtai Pharmaceutical Attractive at Current Levels
  • 5 China Stocks on This Week's Watch List
  • Shengtai Pharma: Cornstarch Not Considered "Industrial Use" of Corn
  • Huifeng Bio-Pharmaceutical Contracts With Xi'an Qinba Xintong Medical
  • China Shenghuo Pharmaceutical Hit on Revenue Decline

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |